The UK’s life sciences industry is set for a major boost, as the Department for International Trade (DIT) has today agreed a ‘BioBridge’ collaboration with the world’s largest medical complex.
The Texas Medical Center (TMC), home to 61 world leading innovators, including the US’ leading cancer hospital, will now offer UK companies a unique package which will help boost exports and drive forward scientific innovation.
British life sciences businesses will have the opportunity to locate themselves at the TMC in Houston, where they will have access to a network of advisors, investors and medical experts.
The partnership will allow for research collaboration on a wide range of medical issues, including the development and advancement of genomics and cancer treatments.
Speaking at an event to celebrate the launch in London today, Minister of State for the Department for International Trade, Baroness Fairhead, said: “The UK is a world leader in healthcare innovation, and this partnership is clear evidence of the opportunities that exist for our companies in exciting markets such as the US.
“Our recently launched Export Strategy will help even more British life sciences companies to reach new markets - bringing together some of the brightest minds in science to advance the availability of innovative healthcare across the globe.”
President & CEO of TMC, William McKeon, said: “This truly unique collaboration is a testament to the Texas Medical Center’s and the United Kingdom’s joint commitment to further fostering the cross-pollination of ideas, people, and innovation in the life sciences.
“We believe this new relationship will serve to create a tactical alliance between TMC and a nation that has been at the forefront of substantial medical innovation for centuries.”
The collaboration is also a step forward for the TMC’s research programme as they look to harness the UK’s world-renowned research and development capability.
Healthcare trusts in Leeds, Cambridge and Manchester are in talks with institutions based at the Houston site and will now look to formalise partnerships.
Former government chief scientist, and current chief executive of UK Research and Innovation, Sir Mark Walport, said: “This unique opportunity will prove to be a valuable asset to UK and US healthcare professionals who are working tirelessly on the advancement of medical treatments for people all over the world.
“With the recognition of the UK as a leader in research and development, I hope to see further collaboration between the Texas Medical Center and the UK in the near future.”
Our BQ Bulletin emails will land in your inbox at 7.30am, Monday to Friday, with a mix of the latest local business news, national news, and features to inspire you. Sign up here!
Click here to read our privacy statement